Systematic Review
Accepted on 29 Jul 2024
Efficacy and safety of lenvatinib plus pembrolizumab in patients with advanced and recurrent endometrial cancer: A systematic review and meta-analysis
in Cancer Immunity and Immunotherapy
Systematic Review
Accepted on 29 Jul 2024
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 29 Jul 2024
in Vaccines and Molecular Therapeutics
Original Research
Accepted on 29 Jul 2024
in Children and Health
Review
Accepted on 29 Jul 2024
in Experimental Pharmacology and Drug Discovery
Review
Accepted on 29 Jul 2024
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 29 Jul 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 29 Jul 2024
in Genomics of Plants and the Phytoecosystem
Original Research
Accepted on 29 Jul 2024
in Statistical Genetics and Methodology
Original Research
Accepted on 29 Jul 2024
in Vaccines and Molecular Therapeutics
Original Research
Accepted on 29 Jul 2024
in Ocean Observation
Review
Accepted on 29 Jul 2024
in Children and Health
Original Research
Accepted on 29 Jul 2024
in Oncology in Veterinary Medicine
Original Research
Accepted on 29 Jul 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 29 Jul 2024
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Accepted on 29 Jul 2024
in Thoracic Oncology
Original Research
Accepted on 29 Jul 2024
in Neuroendocrine Science